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Abstract A method of microextraction by packed sorbent
(MEPS) followed by liquid chromatography with diode array
detection has been developed and optimized for the extraction of
six tricyclic antidepressants (amitriptyline, nortriptyline, imipra-
mine, desipramine, doxepin, nordoxepin) from human serum.
The optimal parameters of MEPS extraction (type of sorbent,
volume of sample, composition, and volume of washing and
elution solutions) for these drugs in spiked samples were
defined. The developed MEPS procedure was validated and
then successfully applied to the analysis of serum reference
material. The limit of detection (0.02–0.05 μg/mL), intraday
(2.7–8.8%) and interday (4.4–11.6%) precision (RSD), and the
accuracy of the assay (94.5–108.8%) at three concentration
levels—0.2, 0.5, and 0.8 μg/mL—were estimated. The accuracy
ofthemethodwasevaluatedbytheanalysisofcertifiedreference
material. Moreover, the validated procedure was compared with
the solid-phase extraction technique. Finally, microextraction by
packed sorbent was assessed as a suitable tool in forensic and
clinical methods for serum sample preparations.
Keywords Tricyclic antidepressant drugs.Microextraction
by packed sorbent.Solid-phase extraction.
High-performance liquid chromatography.
Human serum samples
Abbreviations
Ami Amitriptyline
BIN Barrel insert and needle assembly
Clo Clomipramine
Des Desipramine
Dox Doxepin
GC-MS Gas chromatography with mass
spectrometry detection
HPLC-DAD High-performance liquid chromatography
with diode array detection
Imi Imipramine
IS Internal standard
LC-UV Liquid chromatography with
ultraviolet detection
LLE Liquid–liquid extraction
LOD Limit of detection
LOQ Limit of quantification
LPME Liquid–liquid microextraction
MeOH Methanol
MEPS Microextraction by packed sorbent
Nord Nordoxepin
Nort Nortriptyline
SCX Cation exchange sorbent
SPE Solid-phase extraction
SPME Solid-phase microextraction
SSRIs Selective serotonin reuptake inhibitors
TCADs Tricyclic antidepressants
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Drug analysis in biological fluids is a very important
process for the determination of the physiological perfor-
mance of a drug for toxicological and clinical purposes [1].
Moreover, the most laborious part of the analytical
procedure, which usually takes approx. 80% of the total
analysis time, is the sample preparation of materials of this
kind [1–4]. Such biological matrices as blood, serum, or
urine are quite complex due to the presence of proteins and
other substances with similar chemistry to the analytes
[2, 3]. Thus, it is crucial to select correctly a pretreatment
step and an extraction method. Nowadays, in clinical and
toxicological laboratories, various sample preparation
techniques are applied. The most popular are LLE and
solid-phase extraction (SPE). The mechanism of these
techniques has been thoroughly investigated.
On the other hand, recently, more efficient and less
time- and solvent-consuming techniques compared with
the ones mentioned above have been developed—in
particular, ones in which the isolation process has been
miniaturized [1, 5, 6]. Major examples are SPME [1, 7],
LPME [8, 9], and microextraction by packed sorbent
(MEPS) [1, 2]. The latter is a modern isolation technique
based on the miniaturization of a traditional full-scale
solid-phase extraction technique [1, 4, 5]. In MEPS, a
sorbent is placed within a special needle or barrel, acting
as a cartridge. This technique requires several steps:
conditioning, application of a studied sample, sorbent
washing, and desorption of analytes from the cartridges.
These steps seem to be similar to the SPE method, but for
MEPS, the sample preparation time, the sample volume,
and the organic solvent consumption are significantly re-
duced. Moreover, the MEPS sorbent may be used about 30–
100 times for biological material preparation [10–12]. By
comparison, the typical SPE cartridges are recommended for
single use only. Additionally, the MEPS may be connected
off-line and on-line with an LC or GC system [2, 3, 5].
MEPS was invented and developed in the laboratories of
AstraZeneca in Sweden [4–6]. The first communication
about the application of this technique to chemical and
toxicological analysis was published in 2004 [5].
Abdel-Rehim reported the successful application of the
MEPS method connected on-line with GC-MS to the
determination of local anesthetics in human plasma. Since
that date, microextraction by packed sorbent, thanks to
the various numbers of packing beds (C2, C8, C18, C8-SCX,
and molecularly imprinted polymers), has been used to
isolate a wide range of organic substances, such as local
anesthetics and their metabolites [5, 6, 13], statins [11],
anticancer agents [12, 14], new-generation antidepressants
[15, 16], methadone [17], and illegal drugs [2, 18], in
difficult biological matrices, e.g., plasma [19], urine [10],
saliva [16], and even human hair [18]. Recently, Abdel-
Rehim [20] published a tutorial on microextraction by packed
solvent, discussing this new applied sample preparation
methodfordruganalysiscombinedwithLC-MSandGC-MS.
The most interesting study for the authors of the present
paper—due to the subject of the research—was performed
by Chaves et al. [15]. In their work, microextraction in
packed sorbent and liquid chromatography with UV
detection was applied to the determination of new-
generation antidepressants (sertraline, mirtazapine, fluoxe-
tine, citalopram, paroxetine) in human plasma. The opti-
mized method was adequate for an analysis of the studied
drugs at levels ranging from therapeutic to toxic. The
accuracy of the MEPS/LC-UV method for new antidepres-
sants determination was within a range from 84% to 97%.
However, to the authors’ knowledge, there has only been
one paper, by Malik et al., describing the application of
microextraction in packed sorbent to the isolation of
tricyclic antidepressant drugs—imipramine, amitriltyline,
and clomipramine—from spiked human plasma and urine
[21]. The validation (including accuracy assessment) was
performed using spiked biological fluid samples.
Within the framework of this research, a method of
microextraction in packed sorbent followed by high-
performanceliquidchromatographywithdiodearraydetection
was developed, optimized, and validated for the analysis of
tricyclic antidepressants (TCADs) and their metabolites
(amitriptyline, desipramine, doxepin, imipramine, nordoxepin,
nortriptyline) in human serum.
Experimental
Reagents and materials
HPLC gradient grade acetonitrile and methanol were supplied
by Merck (Darmstadt, Germany); 85% phosphoric acid, 30%
NaOH aqueous solution, sodium chloride, formic acid, acetic
acid, ethyl acetate, chloroform, isopropyl alcohol, 25%
aqueous solution of ammonium and dichloromethane, all of
analytical grade, were purchased from POCH (Gliwice,
Poland). Drug standards of amitriptyline (Ami), desipramine
(Des), doxepin (Dox), imipramine (Imi), nordoxepin
(Nord), nortriptyline (Nort), and clomipramine (Clo)—
all solid hydrochloride salts and diethylamine—were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Deionized water (<1.0 μS/cm) was used throughout.
Human serum was provided courtesy of the local blood
bank (Kraków, Poland). The reference lyophilized serum
samples (high-range tricyclic antidepressants V—serum
toxicology control, toxicology quality control materials:
Clinical & Forensic, LOT no. 2121) containing four
triyclic antidepressant drugs—desipramine, nortriptyline,
2250 R. Wietecha-Posłuszny et al.imipramine, and amitriptyline—were obtained from
UTAK Laboratories, Inc. (Valencia, CA, USA).
Standards
Drug stock solutions (10 mg/mL) were prepared in
methanol and stored in a refrigerator (+4 °C). Spiking
solutions were prepared by appropriately diluting stock
solutions with water. Working standard drug mixtures were
prepared by adding a suitable amount of spiking solution to
water. For determination of extraction efficiency at the
optimization step, a comparative water-based standard
containing each drug—Ami, Des, Dox, Imi, Nord, Nort—
was spiked at concentrations of 1.15 and 0.63 μg/mL to
water (Clo, 4.0 μg/mL).
Apparatus and conditions
Merck-Hitachi LaChrom high-performance liquid chroma-
tography system consisted of an L-7100 pump and L-7455
programmable diode array detector module coupled to a
PC with D-7000 HSM software (Darmstadt, Germany).
The mobile phase was prepared by mixing acetonitrile
and phosphoric buffer (40:60, v/v). Phosphoric buffer
(pH 2.36) was prepared by adding 1.4 mL of 85%
phosphoric acid and 1 mL of diethylamine to a volumetric
f l a s k( 1L )a n df i l l i n gu pw i t hd e i o n i z e dw a t e rt ot h em a r k .
Before analysis, the mobile phase was filtered with a
modified cellulose filter (0.45 μm) by Sartorius (Goettingen,
Germany) and degassed in an ultrasonic bath for
15 min. In each analysis, 10 μL of sample was injected
by an autosampler and the separation carried out in
isocratic mode using a Spheri-5 C18 column, 100×4.6-mm I.
D., particles 5 μm by PerkinElmer (Waltham, MA, USA) for
25 min. The flow rate was 1 mL/min. The column was
thermostated at 50 °C. Chromatograms were acquired at
210 nm and the calibration curves calculated using peak
height ratios (drug/internal standard (IS)).
The MEPS system containing a 250-μL syringe coupled
with barrel insert and needle assemblies (BINs) packed with
C18, C8, and C8-SCX sorbents (4 mg) was purchased from
SGE (Melbourne, Australia). All steps of the MEPS
procedure were carried out manually (off-line). The SPE
J.T. Baker system with Bond Elut Certify (130 mg, 3 mL)
was purchased from Varian (Palo Alto, CA, USA).
Sample preparation
The water samples which were used during the optimization
step were prepared by adding spiking solution to a 100-mL
flask and diluting with 0.9% NaCl to the mark of the
volumetric flask. The concentration of each drug was
0.25 μg/mL. A pH modifier was added to the water
samples before MEPS extraction. For C8 and C18
BINs, 100 μL of 1 M NaOH and for C8-SCX
100 μLo fw a t e rw e r ea d d e dt o1m Lo fs a m p l e .
Drug-free human serum was stored at +4 °C. Of the
serum samples, 500 μL was spiked with spiking solutions
of all analyzed TCADs to 0.25 μg/mL and diluted 1:1 with
water just before analysis. In the validation step, the diluted
drug-free serum was spiked with all six analytes within the
range 0.13–1.00 μg/mL and with internal standard (20 μL
of 100 μg/mL solution) to a concentration of 2 μg/mL.
The human serum reference material was prepared
according to the recommendations given by the manu-
facturer by dissolving lyophilized material with 5 mL of
deionized water. Then, 500 μL of the reference serum
was diluted 1:1 with water and finally spiked with IS
(20 μLo f1 0 0μg/mL of IS solution).
Extraction procedure
MEPS condition
MEPS was performed using a 250-μL volume syringe.
Before being used for the first time, a BIN was conditioned
with 250 μL of methanol followed by 250 μL 0.1% formic
acid. After that, 5×50 μL of spiked human serum diluted
with water (1:1, v/v) was drawn through a BIN very slowly
to provide sufficient interaction between the analytes and
the sorbent. Then, to remove interfering agents, the BIN
was washed with 4×50 μL of 0.1% formic acid and next
dried by blowing 2×50 μL of air. In the following step, the
analyzed drugs were eluted by 4×100 μL of methanol/
water/ammonia solution (25%, 95:4:1, v/v/v) to Eppendorf
vials (500 μL). The MEPS cartridge was rinsed with 2×
250 μL of methanol and then 250 μL of 0.1% formic acid
to be ready for preparation of the following sample. After
use, the cartridge was filled with methanol, sealed, and
stored at room temperature.
The eluate was evaporated under nitrogen stream with
mild heating (42 °C). Dry residues were dissolved in 50 μL
of appropriate medium: with IS (4 μg/mL)—during
optimization or just 0.05% phosphoric acid—in the
validation study. The obtained solution was finally trans-
ferred to HPLC vials (100-μL capacity).
SPE conditions
The SPE procedure was taken from an application note
by Varian developed for the extraction of tricyclic
antidepressants from serum. One milliliter of the spiked
serum sample was diluted with 4 mL 0.1 M phosphate
buffer (pH 6.0) and mixed. Before extraction, the SPE
cartridge was conditioned with 2 mL of methanol, 2 mL
of water, and 1 mL of 0.1 M phosphate buffer (pH 6.0)
Application of MEPS to isolation of psychotropic drugs 2251using low vacuum (<3 in. Hg). Then, the sample was
applied at low speed (1–2 mL/min). After that, the
cartridge was washed with 3 mL of water and 1 mL of
1 M formic acid followed by 3 mL of methanol. The
sorbent was next dried under vacuum for 5 min. The
studied analytes were eluted with 2 mL of dichloro-
methane/isopropyl alcohol/ammonia solution (25%,
78:20:2, v/v/v) to a glass vial. In the next step, the
extraction solvent was evaporated under a nitrogen stream
with mild heating (42 °C). Dry residues were treated the
same way as in the MEPS procedure.
Results and discussion
Optimization of MEPS conditions
Within the framework of this research, a few factors, such
as the kind of MEPS sorbent, draw–eject volume, and
MEPS procedure, were evaluated to determine the optimal
procedure for the isolation of six TCAD drugs from serum
samples. At the beginning, all experiments were performed
with 0.9% NaCl aqueous solution, and then the method was
applied to serum samples.
Optimization using water-based samples
First of all, every step of the MEPS procedure, including
the conditioning of sorbent, washing, and the elution of
analytes, was developed. As tricyclic antidepressants are
usually isolated by solid-phase extraction using C8, C18,
and C8-SCX sorbents [22], MEPS cartridges with the same
bed types were chosen in our study. Every sorbent was
evaluated using four different procedures, listed in Table 1.
The choice of solvents and solutions used for cleaning,
conditioning, and washing was based on the kind of drug
analyzed (pKa over 9.5) and the type of MEPS cartridge.
The choice of proposed sets of solvents was carefully based
on previous experiments with solid-phase extraction [22]
and the authors’ routine laboratory work. During the
optimization using water-based samples, 500 μL of sample
solution was drawn and ejected through the cartridge. The
aim of washing solvents was to clean the cartridge of
potentially interfering substances with minimum loss of the
studied compounds. For hydrophobic sorbents such as C8
and C18, a water plug was applied, whereas for the C8-
SCX sorbent, aqueous solutions of formic and acetic acids
and mixtures of water with acetonitrile or methanol were
tested. After the washing step, sorbents were dried by
blowing of 100 μL of air. At the elution step, for non-polar
beds, elution is faster and more efficient when solvents with
medium polarity are applied. This is why a mixture of
short-chain alcohols with chloroform or water without
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2252 R. Wietecha-Posłuszny et al.ammonia solution (or with ammonia solution to evaluate
differences between non-polar and mixed beds) or even
pure methanol was applied. In the case of elution from
mixed beds, containing non-polar sorbents and cation
exchangers, these also have to be provided with medium
polar solutions, but significantly alkalized with ammonia.
After use, the BINs (C8, C18, and mixed bed) were always
cleaned with 500 μL of methanol.
The carryover between samples was controlled by the
analysis of a blank sample. This was always done after
a sample at the highest concentration of TCADs (1 μg/
mL) in serum. As the blank sample gave no peaks
within the time corresponding to the analyzed drugs, the
carryover was estimated to be significantly less than the
LOD of the method.
At this step, in order to find the best way of sample
preparation and MEPS procedure for each evaluated
sorbent, water-based samples spiked with all the studied
TCADs were analyzed in 12 separate experiments, repeated
five times. Evaluation of the obtained results was per-
formed using a function F, which was based on the mean
peak height corresponding to the six analytes obtained
within a set of five extractions. As an analytical procedure
should provide precise results, the repeatability of
extraction was also taken into account:
F ¼
F0
maxðF0Þ
F0 ¼ H   k2
where max(F′) is the maximum value of function F′ in a set
of tested procedures, H is the mean peak height
corresponding to each of six analytes obtained within the
set of five extractions, and k is the number of analytes
giving the repeatability of peak height corresponding to
each of the six analytes obtained within the set of five
extractions with RSD ≤10%. According to the proposed
approach, function F′ increases together with H when the
extraction efficiency is also high for every drug. As the
H value is an average, it represents the extraction
efficiency for all the analyzed TCADs. Function F′ also
increases with the k value; however, k ranges from 0
(repeatability of peak height worse than 10% RSD for all
analytes) to 6 (RSD ≤1 0 %o fp e a kh e i g h tf o ra l ls i x
drugs). To provide better comparable results, the F′
function was normalized by its maximum value.
For the C8 sorbent, the best procedure (IV) gave a
repeatability of relative peak height (H, n=5) below 6%
for all TCADs. For the other procedures (I–III), the
repeatability of the analytical signal was very poor (RSD
% more than 25%). The mixed sorbent (C8-SCX) required
different procedures (V–VIII). Among them, procedure V
provided satisfactory results, with RSD% within a range
from 5% to 10%. Unexpectedly, the application of the C18
sorbent also resulted in low repeatability of the peak
height. In the best conditions (procedure IV), the RSD%
varied between 5% and 17%.
In the optimization process, the absolute peak height
was also taken into account as its high values provide
better sensitivity. Among all approaches, procedures IV
(both for C8 and C18) and V (C8-SCX) resulted in the
highest peaks (Fig. 1).
The obtained results of function F are presented in
Table 2. The calculated F values confirmed that procedures
IV (C8) and V (C8-SCX) should be further considered,
while despite providing good sensitivity, the application of
procedure IV with the C18 sorbent turned out to be
unsuitable for further investigation.
Optimization of sample and elution solvent volume
In the next step, the draw–eject sample volume at two
levels of 250 and 500 μL was investigated. A higher
intensity of response (peak height) for all TCADs on the
chromatograms was obtained for a volume of 500 μL.
Although a sample volume of 500 μL provided approx. two
times better sensitivity, the lifetime of each BIN was
subsequently reduced (from 40 analyses to approx. 20–15
analyses). Thus, in this case, the application of MEPS did
not achieve its main goal: being an economic alternative to
SPE. That is why the sample volume of 250 μL was
selected for further analysis.
The elution solvent volume at three levels—100, 200,
and 400 μL—was also evaluated. On the basis of the
obtained results, 400 μL of the elution volume turned out to
Fig. 1 Comparison between the results obtained at optimal extraction
conditions: C8—procedure IV, C18—procedure IV, C8-SCX—
procedure V
Application of MEPS to isolation of psychotropic drugs 2253elute the studied compounds from both C8 and C8-SCX
cartridges with the highest efficiency. The extraction
efficiency was calculated as the ratio of relative peak height
(H/HIS) obtained for an extracted sample to the relative
peak height (H/HIS) obtained from the analysis of a
standard water-based drug mixture spiked at a concentra-
tion of 1.15 μg/mL (the concentration corresponding to
100% extraction efficiency, including enrichment factor).
The concentration of the internal standard was equal in
extracted samples and standard water-based mixtures as IS
was added after the extraction process. The extraction
yields of the analyzed drugs for C8 and C8-SCX were
approximately total (100%). The repeatability of the
calculated extraction efficiency was within the range 2–
9% and 3–10% for C8 and C8-SCX, respectively. The
effect of extraction efficiency for all studied elution
volumes is presented in Fig. 2.
As the sample volume was relatively high, the
volume of conditioning and cleaning solvents also had
to be appropriately adjusted. The conditioning volume
was found to be equivalent to the sample volume to
limit the deterioration of the BIN life. The volume of
cleaning solvent reached as much as 200 μL, but this
amount significantly reduced the amount of unknown
peaks resulting from the biological matrix.
The results of the extraction of TCADs from spiked
water samples using both types of sorbent turned out to be
satisfactory, including no detectable carryover, estimated
for water samples. Thus, both C8 and C8-SCX with their
optimal procedures (IVand V, respectively) were applied to
isolate the studied drugs from human serum samples
(Fig. 3). The extraction efficiency (calculated in the same
manner as for water samples, but including enrichment
factor) for C8-SCX varied from 97% for Des to 111.6%
obtained for Ami. The application of C8 sorbent resulted in
efficiency values ranging from 62.9% (Ami) to 114.7%
(Dox). Repeatability (RSD%) for all analytes was <11% for
both sorbents. A low extraction efficiency of nortriptyline
and amitriptyline was obtained using the C8 sorbent, in
contrast to the high values—similar for all analytes—
calculated for C8-SCX, indicating the mixed sorbent to be
the optimal one.
Comparison of MEPS and SPE
The optimized microextraction by packed sorbent pro-
cedure of the isolation of six TCADs from serum was
then compared with the solid-phase extraction method.
As a reference SPE procedure, the extraction of tricyclic
antidepressants from serum using Bond Elut Certify
(mixed bed, C8-SCX) described in the application note
by Varian was chosen. The obtained extraction efficiency
ranged from 37.4% for Nort (RSD=4.0%) to 101.3%
for Dox (RSD=7.4%). In reference papers, the application
Fig. 3 Extraction efficiency of the studied TCADs from serum
samples using sorbents C8 and C8-SCX
Fig. 2 Comparison between the extraction efficiency for the studied
elution volumes (100, 200, 400 μL) for two sorbents, C8-SCX and C8
Table 2 Values of function F
Procedure Sorbent type
C8 C18 C8-SCX
I 0.02 0.05 –
b
II 0.00
a 0.02 –
b
III 0.01 0.00
c –
b
IV 1.00 0.10 –
b
V –
b –
b 0.85
VI –
b –
b 0.05
VII –
b –
b 0.00
a
VIII –
b –
b 0.00
c
aNo peaks corresponding to analytes detected
bProcedures not tested as they are not suitable for a particular type of
sorbent
cRepeatability (RSD%) for all peaks corresponding to the analytes
were poor (RSD% >10%)
2254 R. Wietecha-Posłuszny et al.of optimized SPE procedures using the same SPE
columns resulted in the following extraction efficiencies:
62% Nort, 63% Clo, 66% Des, 69% Ami, and 82% Imi
[23, 24]. It should be emphasized that the application of
SPE columns resulted in four times larger sample
amounts, and a single sample produced 14 mL of
disposals (procedure [23, 24] produced even more sample
and solvents). In the case of the MEPS procedure, waste
production is only about 1.5 mL per sample.
Method validation
Validation of the off-line MEPS/HPLC-DAD method for
the determination of six tricyclic antidepressants and their
metabolites in human serum was performed. Another
tricyclic antidepressant, clomipramine, was chosen as the
internal standard. The results are presented in Table 3. The
analysis of blank samples (analyte-free serum and water
samples) revealed that there was no agent interfering with
the analyzed tricyclic antidepressants.
The LOD and LOQ were calculated as three and ten
times the standard deviation of the analytical signal at
the 0.2-μg/mL concentration level and slope coefficient
ratio (SD0.2/slope), respectively. The calculated LOD
values ranged from 0.02 μg/mL (Nord, Nort) to 0.05 μg/
mL (Imi, Ami). The linearity range was expressed as the
range from the LOQ to the maximum measured concen-
tration (1 μg/mL) with respect to R
2>0.9995. The
obtained values allowed the determination of TCADs
present in serum both at therapeutic levels and at
concentrations found in lethal cases.
The precision of the developed method, expressed as
the repeatability of the determined concentration, was
e s t i m a t e db ya na n a l y s i so ff i v ed i f f e r e n ts e r u ms a m p l e s
spiked with analytes at concentration levels of 0.2, 0.5,
and 0.8 μg/mL. The measurements were repeated three
times on the next days. In this way, intraday and
interday precision was determined (see Table 3).
The accuracy of the assay (A) was calculated as the ratio
of the found concentration (Cf) to the expected concentra-
tion (Ce) after spiking a sample. It was examined at the
three concentration levels; every level was examined in four
separate experiments.
A ¼
Cf
Ce
  100%
The obtained results from the analysis of four samples
are presented in Table 4. The accuracy of the assay ranged
from 96.8±8.7% (Ami) to 106.0±5.3% (Des) at a low
concentration level (0.2 μg/mL), 94.5±5.3% (Ami) to
103.0±8.8% (Des) at a medium concentration level
(0.5 μg/mL), and from 100.2±6.8% (Dox) to 108.8±2.0%
(Des) at a high concentration level (0.8 μg/mL). The
accuracy of the determination of all studied TCADs
obtained using the MEPS/HPLC-DAD method was com-
pared with those achieved by the SPE/HPLC-DAD method
(see Table 4). In this case, the calculated accuracy values
ranged from 107.5±3.3% (Ami) to 113.7±4.9% (Imi) at a
low concentration level, 101.5±6.5% (Nord) to 106.6±
2.9% (Ami) at a medium concentration level, and from
99.2±3.9% (Nord) to 106.9±3.7% (Dox) at a high
concentration level. According to the obtained results, it
may be stated that both methods are quite similar, providing
nearly 100% accuracy with a suitable precision, especially
in the case of the analysis of biological material.
Table 3 Validation parameters of the MEPS/HPLC method of determination of six TCADs in human serum
Parameter Nord Dox Des Nort Imi Ami
Linearity (μg/mL) LOQ = 1.0 (n=5)
Slope 5.92 3.01 1.68 2.29 1.02 1.56
Intercept −0.013 −0.003 −0.006 −0.002 0.017 0.005
Correlation coefficient, R
2 0.9998 0.9998 0.9997 0.9998 0.9995 0.9996
LOD (μg/mL) 0.02 0.03 0.03 0.02 0.05 0.05
LOQ (μg/mL) 0.08 0.09 0.11 0.08 0.17 0.17
Precision 0.2 μg/mL, RSD (%) Intraday
a 4.2 4.4 5.2 4.1 8.1 8.8
Interday
b 4.4 10.5 5.8 5.7 7.9 11.6
Precision 0.5 μg/mL. RSD (%) Intraday
a 5.0 3.7 3.7 4.0 7.6 5.4
Interday
b 6.2 6.9 6.0 6.4 6.5 7.1
Precision 0.8 μg/mL. RSD (%) Intraday
a 2.7 4.8 3.2 2.9 5.7 4.8
Interday
b 10.3 5.9 10.7 10.8 6.5 8.6
an=5
bn=20 (4 days, within 2 weeks, five replicates each day)
Application of MEPS to isolation of psychotropic drugs 2255In order to determine the accuracy of the MEPS/
HPLC-DAD method, the certified reference material of
human serum was analyzed. The experiment was
performed four times and the obtained results compared
with those achieved by the SPE/HPLC-DAD technique
(Table 5). The determined concentrations fitted in the
expected range reported by the manufacturer for three of
the studied drugs, with the exception of the concentration
of nortriptyline found by MEPS/HPLC-DAD. In this case,
the obtained concentration values varied around a level
higher than the certified concentration range. The analysis
of reference material shows that the optimized MEPS
extraction method coupled with determination by HPLC-
DAD is reliable.
Conclusions
In this research, a novel MEPS/HPLC-DAD method for the
isolation of tricyclic antidepressants from human serum was
developed, optimized, and validated. The developed
method enables the determination of amitryptyline,
nortryptyline, doxepin, nordoxepin, imipramine, and
desipramine within a wide concentration range, with
good accuracy and suitable precision. Compared with
the conventional solid-phase extraction technique,
microextraction by packed sorbent is simpler to per-
form, limiting the volumes of organic solvents and
minimizing costs of analysis. Further reduction of
sample volume is also possible, but in this case,
systems that are more sensitive than DAD detection
have to be applied. Moreover, it does not require almost
any specialized equipment (e.g., vacuum pump) and may be
coupled on-line with GC or HPLC. However, contrary to the
manufacturer’s leaflet, in our study, the cartridges could be
applied more than 40 times for water samples and only about
10 times for serum samples.
The application of the MEPS procedure and equip-
ment at the preparation stage provided satisfying
extraction efficiency. Moreover, the good sensitivity
and precision and the high accuracy of the assay of
tricyclic antidepressant drugs make the MEPS/HPLC-
DAD method a useful tool in clinical laboratories for
therapeutic monitoring of TCADs as well as in forensic
laboratories for their determination at therapeutic and
higher levels in human fluids.
Table 5 Analysis of serum reference material by MEPS/HPLC and SPE/HPLC (n=4)
Parameter Des Nort Imi Ami
Concentration verified by the
manufacturer (μg/mL)
0.40 (0.34–0.46)
a 0.37 (0.31–0.42)
a 0.38 (0.32–0.43)
a 0.37 (0.32–0.43)
a
Found concentration by
MEPS/HPLC (μg/mL)
0.46±0.09 0.43±0.01 0.40±0.01 0.40±0.01
Found concentration by
SPE/HPLC (μg/mL)
0.42±0.16 0.36±0.01 0.40±0.14 0.43±0.04
aExpected range given by the manufacturer
Table 4 Accuracy of the assay of TCADs in human serum obtained after MEPS and SPE extraction (n=4)
Method Drug Low concentration level (μg/mL) Medium concentration level (μg/mL) High concentration level (μg/mL)
Expected Found Accuracy (%) Expected Found Accuracy (%) Expected Found Accuracy (%)
MEPS Nord 0.200 0.199 99.4±4.1 0.500 0.503 100.6±7.5 0.800 0.850 106.2±5.3
Dox 0.194 97.2±4.2 0.483 96.6±2.6 0.801 100.2±6.8
Des 0.212 106.0±5.3 0.515 103.0±8.8 0.871 108.8±1.9
Nort 0.202 100.9±3.9 0.512 102.3±9.3 0.846 108.0±2.0
Imi 0.197 98.2±8.5 0.496 98.9±3.4 0.813 101.6±6.0
Ami 0.194 96.8±8.7 0.473 94.5±5.3 0.805 100.6±3.5
SPE Nord 0.200 0.220 110.1±8.7 0.500 0.515 101.5±6.5 0.800 0.805 99.2±3.9
Dox 0.225 112.4±5.2 0.523 103.9±5.1 0.863 106.9±3.7
Des 0.233 111.6±9.1 0.519 102.8±6.0 0.848 105.1±3.1
Nort 0.220 110.0±8.6 0.517 103.8±3.8 0.850 105.2±2.2
Imi 0.227 113.7±4.9 0.533 106.3±5.5 0.824 101.8±3.8
Ami 0.215 107.5±3.3 0.535 106.6±2.9 0.844 104.7±2.1
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